Buscar
Mostrando ítems 1-10 de 21
Evaluación del impacto del retardo del diagnóstico sobre la evolución clínica y endoscópica en pacientes con enfermedad inflamatoria intestinal, atendidos en dos centros de atención médica en Quito - Ecuador, desde enero 2009 hasta marzo 2017.
(PUCE-Quito, 2018)
Introducción: El conocimiento del comportamiento de la enfermedad inflamatoria
intestinal en nuestro medio es desconocido, considerando tanto que la colitis ulcerosa y
la enfermedad de Crohn pueden tener un retardo del ...
Conventional versus biological therapy for prevention of postoperative endoscopic recurrence in patients with Crohn's disease: an international, multicenter, and observational study
(Intestinal Research, 2015)
Postoperative endoscopic recurrence (PER) occurs in nearly 80% of patients 1 year after ileocecal resection in patients with Crohn's disease (CD). Biological agents were more effective in reducing the rates of PER in ...
Direct retrospective comparison of adalimumab and infliximab in preventing early postoperative endoscopic recurrence after ileocaecal resection for crohn's disease: results from the MULTIPER database
(European Crohn’s and Colitis Organisation (ECCO). Published by Oxford University Press., 2015)
Both adalimumab [ADA] and infliximab [IFX] seem to be effective in the prevention of early postoperative endoscopic recurrence [EPER] after ileocaecal resection in Crohn's disease [CD] patients. There is lack of data with ...
Factors affecting the incidence of early endoscopic recurrence after ileocolonic resection for Crohn's disease: a multicentre observational study
(2017-01-01)
Aim: Early endoscopic recurrence is frequently observed in patients following resection for Crohn's disease (CD). However, factors affecting the incidence of an early postoperative endoscopic recurrence (EPER) have not ...
Evolução clínica e endoscópica na doença de Crohn após o transplante de células-tronco hematopoiéticas
(Universidade Federal de PernambucoUFPEBrasilPrograma de Pos Graduacao em Cirurgia, 2016)
Direct retrospective comparison of adalimumab and infliximab in preventing early postoperative endoscopic recurrence after ileocaecal resection for crohn's disease: results from the MULTIPER database
(European Crohn’s and Colitis Organisation (ECCO). Published by Oxford University Press., 2015)